<DOC>
	<DOC>NCT00179582</DOC>
	<brief_summary>To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS</brief_summary>
	<brief_title>Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS</brief_title>
	<detailed_description>The study will evaluate 2 doses of VSL#3 and placebo over a 4 week period in patients presenting with diarrhea predominant IBS symptoms.</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>IBS diarrhea &lt; 18 years of age Pregnancy/breast feeding concomitant medications to reduce bowel function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>IBS</keyword>
	<keyword>Functional bowel disorder</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>probiotic</keyword>
</DOC>